MINNEAPOLIS, July 27 /PRNewswire-FirstCall/ -- Uroplasty, Inc.
(Nasdaq: UPI) announced today that it will release financial
results for the first quarter ended June 30,
2010, at the market close on Tuesday,
August 10, 2010. The Company will host a conference
call to discuss these results on Tuesday,
August 10, 2010 at 3:30 p.m. Central
Time. David Kaysen, President and Chief Executive
Officer, and Medi Jiwani, Vice
President, Chief Financial Officer and Treasurer, will host the
call. Individuals wishing to participate in the conference
call should dial 888-549-7750. An audio replay will be available
for 30 days following the call at 800-406-7325 (domestic) and
303-590-3030 (international), with the passcode 4337016#.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned
subsidiaries in The Netherlands
and the United Kingdom, is a
medical device company that develops, manufactures and markets
innovative proprietary products for the treatment of voiding
dysfunctions. Our primary focus is the continued
commercialization of our Urgent® PC System, which we believe is the
only FDA-approved minimally invasive neuromodulation device
designed for office-based treatment of urinary urgency, urinary
frequency and urge incontinence - symptoms often associated with
overactive bladder. We also offer Macroplastique®, an
injectable bulking agent for the minimally invasive treatment of
adult female stress urinary incontinence primarily due to intrinsic
sphincter deficiency. Please visit Uroplasty, Inc. at
www.uroplasty.com.
For Further
Information:
|
|
Uroplasty, Inc.
David Kaysen, President and CEO,
or
Medi Jiwani, Vice President,
CFO, and Treasurer,
952.426.6140
|
EVC Group
Doug Sherk
(Investors)
415.896.6820
Chris Gale (Media)
646.201.5431
|
|
|
|
|
|
SOURCE Uroplasty, Inc.